PSIL ETF

$17.74
Screen 3,400+ ETFsFind similar ETFs with lower fees
Showing top 20 of 29 holdings— Unlock all holdings(as of Dec 31, 2025)
#Ticker ↕Name ↕Weight ↓Shares ↕Mkt Value ↕Share ChgSectorIndustry
1ATAI:MUAtai Life Sciences BV12.14%548,603$2.24M••••••••••••••••••••••
2CMPSCompass Pathways Plc Adr8.62%230,910$1.59M••••••••••••••••••••••
3RLMDRelmada Therapeutics Inc Common Stock8.35%319,510$1.54M••••••••••••••••••••••
4SUPNSupernus Pharmaceuticals Inc7.64%28,394$1.41M••••••••••••••••••••••
5MMED:CAMind Medicine Mindmed Inc7.45%102,838$1.38M••••••••••••••••••••••
6NRXPNRX Pharmaceuticals Inc.4.81%328,004$888.9K••••••••••••••••••••••
7ALKS:IEAlkermes Plc4.63%30,580$855.6K••••••••••••••••••••••
8GHRSGh Research Plc4.61%67,112$852.3K••••••••••••••••••••••
9NBIXNeurocrine Bioscienc4.53%5,901$836.9K••••••••••••••••••••••
10CYBN:CACybin Inc4.34%98,058$802.1K••••••••••••••••••••••
11ANROAlto Neuroscience, Inc., Series C4.25%44,077$784.6K••••••••••••••••••••••
12DRUG:CABright Minds Biosciences Inc4.20%9,944$776.0K••••••••••••••••••••••
13TTTXXBlackrock Treasury Trust Instl 624.09%755,900$755.9K••••••••••••••••••••••
14ABBVAbbvie Inc3.64%2,943$672.4K••••••••••••••••••••••
15JNJJohnson & Johnson3.42%3,056$632.4K••••••••••••••••••••••
16NEUPNeuphoria Therapeutics Inc2.82%134,194$520.7K••••••••••••••••••••••
17KTTAPasithea Therapeutics Corp2.13%304,721$393.1K••••••••••••••••••••••
18STIMNeuronetics Inc2.02%270,916$373.9K••••••••••••••••••••••
19IXHL:AUIncannex Healthcare Inc1.29%663,727$237.6K••••••••••••••••••••••
20SILOSilo Pharma Inc1.10%599,507$203.8K••••••••••••••••••••••
9+ more holdings available
See all 29 holdings with sector, industry, share changes & CSV export
Unlock All Holdings — $149 $60/mo
Limited to first 500 subscribers - Cancel anytime

PSIL ETF All Holdings

PSIL holdings total 29 positions. The top 10 holdings account for 67.1% of the fund, led by Atai Life Sciences BV at 12.1%, Compass Pathways Plc Adr at 8.6%, Relmada Therapeutics Inc Common Stock at 8.3%.

PSIL portfolio concentration is relatively high, with the top 10 representing 67.1% of total assets. The largest sector exposure is Health Care at 55.7%.

PSIL sector allocation provides a detailed breakdown. PSIL overlap tool shows how holdings compare to other funds in your portfolio.

PSIL ETF Holdings

27 of 29 holdings

  • 1

    Atai Life Sciences BV

    ATAI:MUUnknown
    12.14%
  • 2

    Compass Pathways Plc Adr

    CMPSHealth Care
    8.62%
  • 3

    Relmada Therapeutics Inc Common Stock

    RLMDHealth Care
    8.35%
  • 4

    Supernus Pharmaceuticals Inc

    SUPNHealth Care
    7.64%
  • 5

    Mind Medicine Mindmed Inc

    MMED:CAHealth Care
    7.45%
  • 6

    NRX Pharmaceuticals Inc.

    NRXPUnknown
    4.81%
  • 7

    Alkermes Plc

    ALKS:IEHealth Care
    4.63%
  • 8

    Gh Research Plc

    GHRSUnknown
    4.61%
  • 9

    Neurocrine Bioscienc

    NBIXHealth Care
    4.53%
  • 10

    Cybin Inc

    CYBN:CAUnknown
    4.34%
  • 11

    Alto Neuroscience, Inc., Series C

    ANROHealth Care
    4.25%
  • 12

    Bright Minds Biosciences Inc

    DRUG:CAUnknown
    4.20%
  • 13

    Blackrock Treasury Trust Instl 62

    TTTXXUnknown
    4.09%
  • 14

    Abbvie Inc

    ABBVHealth Care
    3.64%
  • 15

    Johnson & Johnson

    JNJHealth Care
    3.42%
  • 16

    Neuphoria Therapeutics Inc

    NEUPUnknown
    2.82%
  • 17

    Pasithea Therapeutics Corp

    KTTAUnknown
    2.13%
  • 18

    Neuronetics Inc

    STIMHealth Care
    2.02%
  • 19

    Incannex Healthcare Inc

    IXHL:AUUnknown
    1.29%
  • 20

    Silo Pharma Inc

    SILOHealth Care
    1.10%
  • 21

    Vistagen Therapeutics Inc.

    VTGNUnknown
    0.90%
  • 22

    Numinus Wellness Inc

    NUMI:CAUnknown
    0.79%
  • 23

    Enveric Biosciences Inc

    ENVBUnknown
    0.33%
  • 24

    Clearmind Medicine Inc

    CMND:CAUnknown
    0.06%
  • 25

    Quantum Biopharma Ltd

    QNTM:CAUnknown
    0.00%
  • 26

    Citigroup Commercial Mortgage Trust, Series 2023-Smrt, Class A, 0% 10/12/2040

    Other
    0.00%
  • 27

    Cash

    Other
    -0.13%